AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2013
Dec 16, 2013
34519_dirs_2013-12-16_52adddbb-f82e-427d-a037-2bd810892594.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-12-13
Reporting Person: BRIGHAM MICHAEL F (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-13 | Common Stock, par value $0.10 per share | M | 1000 | $3.1 | Acquired | 156252 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-12-13 | Incentive stock options (right to buy) | $3.1 | M | 1000 | Disposed | 2013-12-17 | common stock (1000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23